Published online before print January 15, 2004, doi: 10.1161/01.ATV.0000117178.94087.ba
© 2004 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
Verapamil Increases the Apolipoprotein-Mediated Release of Cellular Cholesterol by Induction of ABCA1 Expression Via Liver X Receptor-Independent Mechanism
From the Department of Biochemistry, Cell Biology, and Metabolism (S.S., R.A., S.A.-D., S.Y.), Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya, Japan; the Department of Biochemistry and Metabolism (T.N.-M.., N.T., K.I.), National Institute of Health Sciences, Setagaya-ku, Tokyo, Japan; and the Laboratory of Cellular Biochemistry (A.R.T., K.U.), Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
Correspondence to Shinji Yokoyama, Biochemistry, Cell Biology, and Metabolism, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. E-mail syokoyam{at}med.nagoya-cu.ac.jp
Objective— Release of cellular cholesterol and phospholipid mediated by helical apolipoprotein and ATP-binding cassette transporter (ABC) A1 is a major source of plasma HDL. We investigated the effect of calcium channel blockers on this reaction.
Methods and Results— Expression of ABCA1, apoA-I–mediated cellular lipid release, and HDL production were enhanced in cAMP analogue-treated RAW264 cells by verapamil, and similar effects were also observed with other calcium channel blockers. The verapamil treatment resulted in rapid increase in ABCA1 protein and its mRNA, but not the ABCG1 mRNA, another target gene product of the nuclear receptor liver X receptor (LXR). By using the cells transfected with a mouse ABCA1 promoter–luciferase construct (-1238 to +57bp), verapamil was shown to enhance the transcriptional activity. However, it did not increase transcription of LXR response element-driven luciferase vector.
Conclusions— The data demonstrated that verapamil increases ABCA1 expression through LXR-independent mechanism and thereby increases apoA-I–mediated cellular lipid release and production of HDL.
Key Words: calcium channel blocker • verapamil • ABCA1 • HDL • cholesterol • apolipoprotein • macrophage
This article has been cited by other articles:
 |
|
 |
|
  R. Lu, J. Ito, N. Iwamoto, T. Nishimaki-Mogami, and S. Yokoyama FGF-1 induces expression of LXR{alpha} and production of 25-hydroxycholesterol to upregulate the apoE gene in rat astrocytes J. Lipid Res., June 1, 2009; 50(6): 1156 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Gao, Y. Xu, Y. Yang, Y. Yang, Z. Zheng, W. Jiang, B. Hong, X. Yan, and S. Si Identification of Upregulators of Human ATP-Binding Cassette Transporter A1 via High-Throughput Screening of a Synthetic and Natural Compound Library J Biomol Screen, August 1, 2008; 13(7): 648 - 656. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Tamehiro, Y. Shigemoto-Mogami, T. Kakeya, K.-i. Okuhira, K. Suzuki, R. Sato, T. Nagao, and T. Nishimaki-Mogami Sterol Regulatory Element-binding Protein-2- and Liver X Receptor-driven Dual Promoter Regulation of Hepatic ABC Transporter A1 Gene Expression: MECHANISM UNDERLYING THE UNIQUE RESPONSE TO CELLULAR CHOLESTEROL STATUS J. Biol. Chem., July 20, 2007; 282(29): 21090 - 21099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Remaley Old Drug, New Tricks: The Unexpected Effect of Doxazosin on High-Density Lipoprotein Circ. Res., July 20, 2007; 101(2): 116 - 118. [Full Text] [PDF]
|
|
|
|
|
|
N. Iwamoto, S. Abe-Dohmae, M. Ayaori, N. Tanaka, M. Kusuhara, F. Ohsuzu, and S. Yokoyama ATP-Binding Cassette Transporter A1 Gene Transcription Is Downregulated by Activator Protein 2{alpha}: Doxazosin Inhibits Activator Protein 2{alpha} and Increases High-Density Lipoprotein Biogenesis Independent of {alpha}1-Adrenoceptor Blockade Circ. Res., July 20, 2007; 101(2): 156 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Le Goff, M. Settle, D. J. Greene, R. E. Morton, and J. D. Smith Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis J. Lipid Res., January 1, 2006; 47(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yokoyama Assembly of High-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Oram and J. W. Heinecke ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease Physiol Rev, October 1, 2005; 85(4): 1343 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hayashi, S. Abe-Dohmae, M. Okazaki, K. Ueda, and S. Yokoyama Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7 J. Lipid Res., August 1, 2005; 46(8): 1703 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Arakawa, N. Tamehiro, T. Nishimaki-Mogami, K. Ueda, and S. Yokoyama Fenofibric Acid, an Active Form of Fenofibrate, Increases Apolipoprotein A-I-Mediated High-Density Lipoprotein Biogenesis by Enhancing Transcription of ATP-Binding Cassette Transporter A1 Gene in a Liver X Receptor-Dependent Manner Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1193 - 1197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Soumian, C Albrecht, A. Davies, and R. Gibbs ABCA1 and atherosclerosis Vascular Medicine, May 1, 2005; 10(2): 109 - 119. [Abstract] [PDF]
|
|